Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1128 | Neuroendocrinology | ICEECE2012

Right hemicolectomy in the treatment of patients with appendiceal neuroendocrine tumors: does size matter?

Grozinsky-Glasberg S. , Alexandraki K. , Barak D. , Kaltsas G. , Gross D.

Background: A recent study of a small series of patients with appendiceal neuroendocrine tumors (ANETs) fulfilling various criteria for right hemicolectomy (RHC) revealed that ≈ 25% may harbor identifiable extra-appendiceal disease. The residual disease might not have been detected using the latest European Neuroendocrine Tumors Society (ENETs) revised pathological criteria.Aims: To evaluate the latest pathological criteria for completion right hem...

ea0026p81 | Endocrine tumours and neoplasia | ECE2011

Treatment of patients with metastatic well-differentiated gastroenteropancreatic tumors with RAD001(EVEROLIMUS)

Mpanaka I , Antoniou S , Kanakis G , Zilos A , Rousaki P , Schini M , Kampanellou C , Kaltsas G

Purpose: The efficacy and safety of RAD, an mTOR inhibitor, in patients with well differentiated metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NET).Material and methods: We studied seven male patients (mean age 55 years, range 36–75) with well differentiated non functioning stage IV GEP-NETs (five pancreatic, one hindgut carcinoid, and one NET of unknown primary). All received RAD 10 mg/day in combination with long acting octerotide 3...

ea0026p82 | Endocrine tumours and neoplasia | ECE2011

The role and extend of surgical resection in patients with gastric carcinoid tumours type 1

Antoniou S , Zilos A , Mpanaka I , Kanakis G , Rousaki P , Schini M , Griniatsos J , Kaltsas G R

Background: The exact indications and/or the type of operation requiring for the treatment of gastric carcinoids (GC) type 1, are not clearly stated. The present study was designed to evaluate the value of the oncological gastrectomy in the treatment of GC type 1.Materials and method: Between January 2004 and December 2010, we advocated gastric resection in cases of GC type 1 when at least one of the following criteria was present: i) multiple recurrent ...

ea0020p448 | Obesity and Metabolism | ECE2009

Evidence of increased cardiovascular risk in patients with non-secreting unilateral adrenocortical adenomas

Androulakis Ioannis , Kollias George , Markou Athina , Papanastasiou Lambrini , Angnostou Tilemachos , Papamichael Christos , Piaditis George , Kaltsas Gregory

Background: Incidentally discovered adrenal adenomas (AA) are associated with increased prevalence of hypertension, obesity, and impaired glucose tolerance, all established risk factors for cardiovascular (CV) morbidity. However, most studies were performed in patients with AA and autonomous cortsisol and/or aldosterone secretion, whereas the presence of cardiovascular risk in patients with non-secreting AA has not been looked into detail.Methods: Cardio...

ea0011p6 | Bone | ECE2006

Circulating osteoprotegerin and receptor activator of NF- κB ligand system in patients with beta-thalassemia major

Angelopoulos N , Rombopoulos G , Kaltsas D , Kaltzidou V , Katounda E , Tolis G

Objectives: To characterize the possible role of the osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) system in thalassemia-related bone loss.Background: Osteoporosis represents an important cause of morbidity in patients with β-thalassemia major and its aetiology is multifactorial.Methods: Serum concentrations of OPG, RANKL, markers of bone turnover and lumbar spine bone mineral density (BMD) were mea...

ea0073aep555 | Pituitary and Neuroendocrinology | ECE2021

Abberant expression pattern of circadian clock genes in Type 1 gastric neuroendocrine neoplasms compared to ECL hyperplasia

Karapanagioti Angeliki , Daskalakis Kosmas , Nasiri-Ansari Narjes , Vlachou Erasmia , Kyriakopoulos Georgios , Kassi Evanthia , Kaltsas Gregory

PurposeThere is a continuity of changes ranging from enterochromaffin‐like (ECL) cell hyperplasia to type 1 gastric neuroendocrine neoplasms (GNEN1) with important clinical implications. Although the effect of the circadian clock system on tumorigenesis has been addressed, the role of the peripheral clock system in the transition from ECL-cell hyperplasia to GNEN1 remains to be explored.MethodsSix patie...

ea0081p422 | Pituitary and Neuroendocrinology | ECE2022

Aberrant expression of clock genes in human gastric neuroendocrine tumors type 1

Karapanagioti Angeliki , Nasiri-Ansari Narjes , Daskalakis Kosmas , Vlachou Erasmia , Kyriakopoulos Georgios , Randeva Harpal , Kaltsas Gregory , Kassi Eva

Introduction: Gastric neuroendocrine tumors (GNET) are rare gastric neoplasms which are developed due to hypergastrinemia and enterochromaffin-like (ECL) cell hyperplasia. Although the effect of the circadian clock system disruption on tumorigenesis has been already studied in various malignancies and autoimmune diseases, the role of the peripheral clock system in the transition from ECL-cell hyperplasia to GNEN1 (Type 1 Gastric Neuroendocrine Neoplasms) remains unexplored.</p...

ea0081ep937 | Reproductive and Developmental Endocrinology | ECE2022

Melatonin ameliorates glucocorticoid-induced invasiveness and circadian rhythm disruption in human endometrial adenocarcinoma cells

Karapanagioti Angeliki , Nasiri-Ansari Narjes , Kyrou Ioannis , Mavrogianni Despoina , Drakakis Peter , kaltsas gregory , Papavassiliou Athanasios G. , Randeva Harpal , Kassi Eva

Introduction: The biological rhythm pattern is synchronized through circadian oscillation of cortisol and melatonin release. Increased cortisol levels and circadian rhythm disruption act as an oncogenic factor in endometrial cancer through among others- dysregulation of cell proliferation/apoptosis and invasion.Aim: To investigate, whether there is an oscillatory expression of the clock genes, MT1 and GR expression in human endometrial carcinoma cells. T...

ea0041gp23 | Adrenal (2) | ECE2016

Deterioration of indices of insulin resistance in patients with non-functioning and cortisol secreting adrenal incidentalomas during a long term follow-up

Papanastasiou Labrini , Alexandraki Krystallenia , Fountoulakis Stelios , Kounadi Theodora , Markou Athina , Tsiavos Vaios , Androulakis Ioannis , Samara Christianna , Piaditis George , Kaltsas Gregory

Introduction: Adrenal incidentalomas (AI) with or without concomitant autonomous cortisol secretion can be associated with several metabolic alterations that may lead to increased cardiovascular risk. However, data regarding insulin resistance (IR) during long term follow-up of AI are scarce. The aim was to prospectively investigate the presence and evolution of IR in patients with AI between 2003 and 2014.Methods: Seventy three patients with AI for at l...

ea0041ep633 | Endocrine tumours and neoplasia | ECE2016

Mechano growth factor (MGF) expression increased in secondary compared to primary foci in well neuroendocrine neoplasms

Alexandraki Krystallenia , Philippou Anastasios , Boutzios Georgios , Moschouris Panagiotis , Karnezis James , Theohari Irini , Koutsilieris Michael , Delladetsima Ioanna , Kaltsas Gregory

Introduction: Insulin-like growth factor-I (IGF-I) has a role in cell proliferation, differentiation, migration, and survival. By alternative splicing different IGF-I mRNA transcripts as IGF-IEc (mechano growth factor, MGF) or IGF-IEa variants are produced. MGF induces muscle hypertrophy and implicated in the pathophysiology of various types of cancer. Aim of the study was to investigate the role of MGF in the pathophysiology of neuroendocrine neoplasms (NENs).<p class="ab...